Melissa Branham-O'Connor, Ph.D. - Publications
Affiliations: | 2009 | Biological Sciences | Clemson University, Clemson, SC, United States |
Area:
Microbiology Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Branham-O'Connor M, Robichaux WG, Zhang XK, Cho H, Kehrl JH, Lanier SM, Blumer JB. Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3). The Journal of Biological Chemistry. 289: 10738-47. PMID 24573680 DOI: 10.1074/Jbc.M113.515031 | 0.322 | |||
2014 | Bradley A, Zheng H, Ziebarth A, Sakati W, Branham-O'Connor M, Blumer JB, Liu Y, Kistner-Griffin E, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Landen CN, Eblen ST. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 35: 1100-9. PMID 24379240 DOI: 10.1093/Carcin/Bgt489 | 0.388 | |||
2010 | Branham-O'Connor M, Li J, Kotturi HS, Yu X, Wagner TE, Wei Y. Fusion induced reversal of dendritic cell maturation: an altered expression of inflammatory chemokine and chemokine receptors in dendritomas. Oncology Reports. 23: 545-50. PMID 20043120 DOI: 10.3892/Or_00000668 | 0.519 | |||
2010 | Kotturi HS, Li J, Branham-O'Connor M, Yu X, Wagner TE, Wei Y. In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors. Cancer Gene Therapy. 17: 164-70. PMID 19816522 DOI: 10.1038/Cgt.2009.69 | 0.573 | |||
2008 | Kotturi HS, Li J, Branham-O'Connor M, Stickel SL, Yu X, Wagner TE, Wei Y. Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation. Gene Therapy. 15: 1302-10. PMID 18463688 DOI: 10.1038/Gt.2008.77 | 0.581 | |||
Show low-probability matches. |